Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

GLAD: Dose-Finding, Efficacy, and Safety of AZ 242 (Tesaglitazar) in Subjects With Type 2 Diabetes

ClinicalTrials.gov ID: NCT00280865

Public ClinicalTrials.gov record NCT00280865. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 5, 2026, 2:14 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Dose-Finding, Efficacy, and Safety of AZ 242 (Tesaglitazar) in Subjects With Type 2 Diabetes

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a 12-week randomized, double-blind, multi-center, active-controlled (open-label pioglitazone) and placebo-controlled study of tesaglitazar (0.1, 0.5, 1, 2, and 3 mg) in patients with type 2 diabetes, not adequately controlled on diet and lifestyle advice alone during the run-in period. The study comprises a 2-week enrollment period, 4 week placebo single blind run in period followed by a 12-week double blind treatment period and a 3-week follow-up period

Study identification

NCT ID
NCT00280865
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
AstraZeneca
Industry
Enrollment
500 participants

Conditions and interventions

Interventions

Drug · Behavioral

Eligibility (public fields only)

Age range
30 Years to 50 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 31, 2002
Primary completion
Not listed
Completion
May 31, 2003
Last update posted
Jul 30, 2006

2002 – 2003

United States locations

U.S. sites
90
U.S. states
35
U.S. cities
90
Facility City State ZIP Site status
Research Site Birmingham Alabama
Research Site Huntsville Alabama
Research Site Montgomery Alabama
Research Site Mesa Arizona
Research Site Phoenix Arizona
Research Site Tucson Arizona
Research Site Alhambra California
Research Site Anaheim California
Research Site Dinuba California
Research Site Escondido California
Research Site Fresno California
Research Site Greenbrae California
Research Site Long Beach California
Research Site Mission Viejo California
Research Site Orange California
Research Site Sacramento California
Research Site San Diego California
Research Site Walnut Creek California
Research Site Stamford Connecticut
Research Site Waterbury Connecticut
Research Site Washington D.C. District of Columbia
Research Site Brandon Florida
Research Site Coral Gables Florida
Research Site DeLand Florida
Research Site Gainesville Florida
Research Site Hollywood Florida
Research Site Miami Florida
Research Site Atlanta Georgia
Research Site Augusta Georgia
Research Site Blue Ridge Georgia
Research Site Dunwoody Georgia
Research Site Gurnee Illinois
Research Site Springfield Illinois
Research Site Evansville Indiana
Research Site Indianapolis Indiana
Research Site Wichita Kansas
Research Site Louisville Kentucky
Research Site New Orleans Louisiana
Research Site Bangor Maine
Research Site Baltimore Maryland
Research Site Salisbury Massachusetts
Research Site Worcester Massachusetts
Research Site Ann Arbor Michigan
Research Site Cadillac Michigan
Research Site Jackson Mississippi
Research Site St Louis Missouri
Research Site Omaha Nebraska
Research Site Henderson Nevada
Research Site Las Vegas Nevada
Research Site Pahrump Nevada
Research Site Lawrenceville New Jersey
Research Site Newark New Jersey
Research Site Albany New York
Research Site Brooklyn New York
Research Site Buffalo New York
Research Site New Hyde Park New York
Research Site New York New York
Research Site Charlotte North Carolina
Research Site Hickory North Carolina
Research Site Winston-Salem North Carolina
Research Site Canfield Ohio
Research Site Cincinnati Ohio
Research Site Columbus Ohio
Research Site Kettering Ohio
Research Site Lakewood Ohio
Research Site Oklahoma City Oklahoma
Research Site Eugene Oregon
Research Site Altoona Pennsylvania
Research Site Cheswick Pennsylvania
Research Site Penndel Pennsylvania
Research Site Philadelphia Pennsylvania
Research Site Warminster Pennsylvania
Research Site Warwick Rhode Island
Research Site Columbia South Carolina
Research Site Ninety Six South Carolina
Research Site Summerville South Carolina
Research Site Sioux Falls South Dakota
Research Site Arlington Texas
Research Site Corpus Christi Texas
Research Site Dallas Texas
Research Site Lubbock Texas
Research Site North Richland Hills Texas
Research Site San Antonio Texas
Research Site Salt Lake City Utah
Research Site Falls Church Virginia
Research Site Norfolk Virginia
Research Site Richmond Virginia
Research Site Edmonds Washington
Research Site Renton Washington
Research Site Huntington West Virginia

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 20 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00280865, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 30, 2006 · Synced Sep 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00280865 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →